Human trials of the first rejuvenation therapy begin
Clinical trials for Senolytics, developed by UNITY Biotechnology, are currently in phase 1.
We are happy to announce today that UNITY Biotechnology will begin human clinical trials for the first rejuvenation treatment that targets directly one of the aging processes: senescent cell.
The quiet revolution
In our collective imaginations, revolutions begin with a bang. However, most often, technological revolutions are quiet and unnoticed by the majority of people. It’s the same with therapies that target the aging process directly to try and prevent or reverse age related diseases.
Source:
https://www.leafscience.org/the-first-rejuvenation-therapy-reaches-human-trials/
